Purpose: As important ion channels of the central nervous system, calcium channels not only take part in epileptogenesis but also act as the targets of commonly used antiepileptic drugs (AEDs). Thus, this study aimed to provide the first investigation of the association between CACNA1A, CACNA1C, and CACNA1H single nucleotide polymorphisms (SNPs) and AED resistance in the Chinese Han population. Methods: We performed genotyping of tagging single nucleotide polymorphisms (tagSNPs) of CACNA1A, 1C and 1H in 480 Chinese epilepsy patients (288 drug-responsive and 192 drug-resistant patients). The Illumina GoldenGate BeadArray assay was used to detect the genotypes of all of the patients. A total of 15 SNPs were selected based on the HapMap database. The genotype distributions in drug-responsive and drug-resistant patients were compared, and the haplotype frequencies of each gene were calculated. Results: None of the 15 tagSNPs alleles were found to be associated with drug-resistant epilepsy. However, the frequency of the TAGAA haplotype in CACNA1A was significantly higher in drug-resistant patients than in drug-responsive patients after the correction of multiple comparisons with Bonferroni's method (TAGAA 13.3% vs. 7.1%, OR = 2.129 [1.373-3 .299], P = 0.00059 < 0.05/10). Conclusions: This study revealed no association between the 15 tagSNPs of CACNA1A, 1C, and 1H and drug efficacy in the Chinese Han population. The TAGAA haplotype of CACNA1A may be a risk factor for AED resistance.
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the CACNA1A gene. Ca v 1.2 channels, a subtype of L-type channels, are primarily located in the postsynaptic dendrites [11] , and its a 1C subunit, which directs the activity, is encoded by the CACNA1C gene. Cav3.2 channels, a subtype of T-type channels, are expressed at cell bodies and dendrites [12] , and its a 1H subunit is encoded by the CACNA1H gene. It is known that genetic factors may play an increasingly important role in both the pathogenesis of epilepsy and AED efficacy [13] . Previous studies in genetic mouse models and epilepsy patients have demonstrated that dysfunction of the CACNA1A gene may be associated with epilepsy [14, 15] . CACNA1H has been identified as a susceptibility gene of childhood absence epilepsy (CAE), particularly in Han Chinese population [16, 17] . A recent study noted an upregulation of the a 1c subunit of Cav1.2 in the hippocampal tissue of patients with temporal lobe epilepsy (TLE), suggesting that CACNA1C may be involved in the pathogenesis of TLE [18] . In addition, a number of association studies have revealed that single nucleotide polymorphisms (SNPs) may be predictors of AED resistance. For instance, in sodium channels, which are also targets of AEDs, rs3812718 [19] in the SCN1A gene has been proved to be associated with drug-resistant epilepsy.
The above-mentioned three types of calcium channels not only play an important role in epileptogenesis but also act as the targets of commonly used AEDs. However, to date, the relationship between polymorphisms of calcium channel genes and AED efficacy has not yet been investigated. In this study, we aimed to determine the association between CACNA1A, CACNA1C, and CACNA1H SNPs and resistance of AEDs in the Chinese Han population.
Materials and methods

Ethical approval
This study was approved by the Ethics Committee of Xiangya Hospital, Central South University. All of the patients or their parents were provided informed written consent before enrolment in this study.
Subjects
A total of 480 outpatients suffering from idiopathic epilepsy were recruited (301 males, 179 females, mean age: 23.6 AE 13.4 years) from Xiangya Hospital, the Second Xiangya Hospital of Central South University and Hunan Provincial People's Hospital. The patients were diagnosed and classified based on the guidelines of the International League Against Epilepsy (ILAE, 2010). The exclusion criteria included severe adverse drug reactions, unreliable records of seizure frequency, poor compliance with AEDs, cerebral trauma, tumour and infection, cerebrovascular disorders, cerebral immunologic disorders, degenerative and other neurological disorders, significant psychiatric comorbidity, presence of progressive systemic disorders and history of alcohol or drug abuse. A standardized questionnaire was administered to collect demographic details and clinical data, which included seizure types and frequencies, electroencephalography (EEG), magnetic resonance imaging (MRI), past medical history, AED history, concomitant drug history, and relevant family history. All AEDs used were appropriately chosen for each patient based on the seizure type or epilepsy syndrome.
Phenotyping
The phenotypes of AED responsiveness and resistance were defined on two levels according to the consensus definition proposed by the ILAE in 2010 [20] . The first level evaluates the efficacy of each antiepileptic drug and classifies the results during the evaluation period, which is at least three times the longest inter-seizure interval prior to starting a new intervention and not less than 12 months, into the general categories ''seizure-free,'' ''treatment failure,'' and ''undetermined''. The second level provides a core definition of drug-resistant epilepsy. Drug responsiveness was defined as a successfully seizure-free evaluation period, and drug resistance was defined as failure of adequate trials of two appropriate tolerated antiepileptic drug schedules (whether as monotherapies or in combination) to achieve a sustained period free of seizures. The types of epileptic seizures and the appropriate use of antiepileptic drugs were decided by at least two experienced attending physicians according to the patient's condition and auxiliary examinations.
Genotyping
The DNA from the peripheral blood of the participants was isolated using the phenol-chloroform method. The tagSNPs in CACNA1A, 1C and 1H were selected based on the HapMap database (http://www.Hapmap.org/) by applying the CHB data source (Chinese Beijing; SNP genotype data Rel 27 phase II+III, Feb09). In the HapMap database, CACNA1A was selected and zoomed out 10% to include the flanking regions, resulting in a length of 329. Table 1 . All of the selected SNPs were in accordance with Hardy-Weinberg equilibrium in the Chinese Han population. Genotype detection was performed through the Illumina GoldenGate BeadArray assay.
Statistical analysis
The SPSS software package (version 20.0 for Windows) was used for the statistical analyses. The ages of the drug-responsive and drug-resistant patient groups was compared by Student's t-test. The gender and other characteristics of the patients were compared by x 2 test. The relationship between the genotypes and phenotypes were examined by binary logistic regression. The linkage disequilibrium and haplotypes were analyzed using SHEsis (http://analysis.bio-x.cn/myAnalysis.php). With a test level a of 0.05, the p-value <0.05 was accepted to define statistical significance. Bonferroni's method was used for the correction of multiple comparisons.
Results
The study population consisted of 288 AED responders (23.3 AE 14.3 years) and 192 resistant patients (24.2 AE 11.8 years). There was no significant difference in the distributions of age, sex, initial seizure frequency and seizure types between the two groups. The most commonly used AEDs was valproic acid (42.7%), followed by oxcarbazepine (27.7%), lamotrigine (25.4%), phenytoinum (14.8%), levetiracetam (13.3%), phenobarbital (8.3%) and topiramate (7.9%) ( Table 2) . We detected five tagSNPs in CACNA1A, five tagSNPs in CACNA1C, and five tagSNPs in CACNA1H in the drug-resistant and drug-responsive patients, and we found no significant difference in the distribution of genotype and allele frequencies ( Table 3) .
The linkage disequilibrium tests of the SNPs in CACNA1A, 1C and 1H are shown in Figs. 1-3 , respectively. The rs2074880 and rs16030 loci in CACNA1A were in strong linkage disequilibrium (D' = 0.777). The rs215976 and rs216008 loci in CACNA1C were in strong disequilibrium (D' = 0.742). In addition, the rs7191246 and rs3794619 loci in CACNA1H were in strong disequilibrium (D' = 0.871).
The haplotype calculation revealed that the frequency of the TAGAA haplotype in CACNA1A was significantly higher in the drug-resistant patients than in the drug-responsive patients after the correction of multiple comparisons with Bonferroni's method (TAGAA 13.3% vs. 7.1%, OR = 2.129 [1.373-3.299], P = 0.00059 < 0.05/10 as shown in Table 4 . We did not find statistic significant haplotypes in CACNA1C and CACNA1H.
Discussion
Genetic polymorphisms can alter the drug metabolism at various stages, including the absorption, distribution, transport, action, metabolism and clearance of AEDs [1] . A large number of association studies have attempted to analyze the pharmacogenomics of resistant epilepsy with respect to drug transporters (ABCB1 and ABCC2), drug targets (mainly focusing on sodium channels), GABA pathways, the cytochrome p450 family and even inflammatory factors [21] . However, there remains a large gap between the high incidence of drug-resistant epilepsy and the genetic variants that have been explored.
It has been proven that Ca v 2.1 channels play a crucial role in modulating neurotransmitter release. Dysfunction of these channels may impair the balance between neuronal inhibition and excitation leading to burst firing [14] . Cav1.2 not only regulates transcription by activating the transient inward calcium current but also participates in neural development and plays an important role in coupling neuronal excitation with Ca v 1.2-mediated Ca 2+ signalling, which makes Ca v 1.2 an effective regulator of signalling pathways [11] . T-type calcium channels generally open and close at approximately similar membrane potentials, which can be activated rapidly at low voltages, leading to depolarization of the membrane and the generation of low threshold spikes (LTS) involved in ''burst firing'' and thalamocortical synchronization oscillation, which may have a close relationship with epilepsy [22] . AEDs are thought to generate antiepileptic effects through calcium channels by altering the calcium influx, influencing the excitability of neurons and potentially regulating the balance of neurotransmitters [23, 24] . In this study, we aimed to determine the association between common variations of the CACNA1A, 1C, and 1H genes and AED resistance in the Chinese Han population. However, we found no statistically significant difference between the 15 SNPs of the three genes and drug-resistant epilepsy. However, interestingly, we found a meaningful haplotype in CACNA1A, namely TAGAA, which may be a risk factor for AED resistance. To the best of our knowledge, the processes of drug-resistance can be influenced by various genes, environmental factors and their interactions. Because single nucleotide polymorphisms (SNPs) are limited, we also analyzed the haplotypes of the three genes. Although the exact mechanism remains unknown, some published reports have shown that dysfunction of calcium channels can influence the calcium ion flow and further impact the receptors, which may be the underlying cause of drug-resistant epilepsy. More specifically, calcium ion flow changes can cause stochastic lesions of mitochondrial DNA and affect non-transcriptional or posttranscriptional processes, which may potentially alter the sensitivity of drug targets and thereby increase the likelihood of drug resistance [25] .
Calcium channels play an important role in the generation of epilepsy, participate in antiepileptic processes and may even affect the plasticity of receptors. To improve the accuracy of the group, we applied new definitions to drug resistance and drug responsiveness according to the guidelines of the International League Against Epilepsy (ILAE, 2010). In addition, because epilepsy is a very complex neurological disease, we also analyzed various subgroups, including partial seizure, generalized seizure and non-classifiable seizure groups, and found no positive association (data not shown). Several factors may explain our results: First, because many AEDs appear to work through multiple mechanisms and the inherited component of the response to drugs is typically polygenic, it is complicated to find the real reason underlying drug resistance. Second, this study only tested some of the SNPs and did not use a sequencing approach to detect other potential SNPs or genetic variants within these genes. Third, based on the limited sample size in our study, the MAF of the selected SNPs was greater than 5%, and rare SNPs, which may play an important role in AED resistance, were overlooked. Fourth, different ethnic backgrounds should also be taken into account because these may give rise to different SNP distributions. Thus, additional data from different races should be collected in future studies.
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